Genes in panel
STRs in panel
Prev Next
Regions in panel
Prev Next

Prepair 1000+

Gene: CLN3

Amber List (moderate evidence)

CLN3 (CLN3, battenin)
EnsemblGeneIds (GRCh38): ENSG00000188603
EnsemblGeneIds (GRCh37): ENSG00000188603
OMIM: 607042, Gene2Phenotype
CLN3 is in 15 panels

3 reviews

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

Comment when marking as ready: Downgrade to Amber until CNV analysis included.
Created: 24 Apr 2025, 5:09 a.m. | Last Modified: 24 Apr 2025, 5:09 a.m.
Panel Version: 1.2085

Lilian Downie (Victorian Clinical Genetics Services)

Comment when marking as ready: Consider exclusion (Amber) as we will miss a high proportion of cases due to the founder variant being a 1kb deletion
Created: 3 Apr 2025, 1:14 a.m. | Last Modified: 3 Apr 2025, 1:14 a.m.
Panel Version: 1.1822

Marta Cifuentes Ochoa (Victorian Clinical Genetics Services)

Green List (high evidence)

Well established gene disease association.

Severe neurodegenerative disorder.

HGNC approved symbol/name: CLN3
Is the phenotype(s) severe and onset <18yo ? Y
Known technical challenges? Y, founder variant for Batten disease in CLN3 is a 1.02 kb deletion estimated to account for ~75-95% of pathogenic variants, 90% in Finland.
Gene reported in >3 independent families
Created: 18 Nov 2024, 1:18 a.m. | Last Modified: 18 Nov 2024, 1:18 a.m.
Panel Version: 1.547

Mode of inheritance
BIALLELIC, autosomal or pseudoautosomal

Phenotypes
Ceroid lipofuscinosis, neuronal, 3, MIM# 204200; MONDO:0008767

Publications

History Filter Activity

24 Apr 2025, Gel status: 2

Removed Tag

Seb Lunke (Victorian Clinical Genetics Services)

Tag for review was removed from gene: CLN3.

24 Apr 2025, Gel status: 2

Entity classified by Genomics England curator

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

Gene: cln3 has been classified as Amber List (Moderate Evidence).

24 Apr 2025, Gel status: 2

Entity classified by Genomics England curator

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

Gene: cln3 has been classified as Amber List (Moderate Evidence).

3 Apr 2025, Gel status: 3

Entity classified by Genomics England curator

Lilian Downie (Victorian Clinical Genetics Services)

Gene: cln3 has been classified as Green List (High Evidence).

3 Apr 2025, Gel status: 3

Added Tag

Lilian Downie (Victorian Clinical Genetics Services)

Tag for review tag was added to gene: CLN3.

18 Nov 2024, Gel status: 3

Set publications

Lilian Downie (Victorian Clinical Genetics Services)

Publications for gene: CLN3 were set to 7553855; 31926949

18 Nov 2024, Gel status: 3

Added Tag

Lilian Downie (Victorian Clinical Genetics Services)

Tag SV/CNV tag was added to gene: CLN3.

22 Aug 2024, Gel status: 3

Entity classified by Genomics England curator

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

Gene: cln3 has been classified as Green List (High Evidence).

22 Aug 2024, Gel status: 3

Set Phenotypes

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

Phenotypes for gene: CLN3 were changed from Ceroid lipofuscinosis, neuronal, 3, 204200 (3) to Ceroid lipofuscinosis, neuronal, 3, MIM# 204200; MONDO:0008767

22 Aug 2024, Gel status: 3

Set publications

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

Publications for gene: CLN3 were set to

2 Nov 2023, Gel status: 3

Set Phenotypes

Seb Lunke (Victorian Clinical Genetics Services)

Added phenotypes Ceroid lipofuscinosis, neuronal, 3, 204200 (3) for gene: CLN3

1 Jun 2022, Gel status: 3

Created, Added New Source, Set mode of inheritance, Set Phenotypes

Zornitza Stark (Victorian Clinical Genetics Services; Australian Genomics)

gene: CLN3 was added gene: CLN3 was added to Reproductive Carrier Screen_VCGS. Sources: Mackenzie's Mission,Expert Review Green Mode of inheritance for gene: CLN3 was set to BIALLELIC, autosomal or pseudoautosomal Phenotypes for gene: CLN3 were set to Ceroid lipofuscinosis, neuronal, 3, 204200 (3)